Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbubble ultrasound contrast agents are suspensions of gas-filled microbubbles (typically perfluorocarbon, sulfur hexafluoride, or nitrogen) encapsulated within shells made from lipids, proteins, or polymers. When injected intravenously, they remain confined within the vascular system due to their size, behaving as intravascular contrast agents. Upon exposure to ultrasound waves, microbubbles undergo volume oscillations at diagnostic frequencies (1–15 MHz), resonating and emitting sound at harmonic and sub-harmonic frequencies. The dramatic acoustic impedance mismatch between the gas in the microbubble and surrounding blood/tissue yields strong nonlinear reflection and scattering, greatly enhancing blood pool visualization by ultrasound. Higher acoustic pressure can cause inertial cavitation, leading to rapid bubble collapse and possible tissue microinjury, which is being explored therapeutically but carries safety considerations. These agents do not represent molecular targets for drug action but are increasingly used for molecular imaging and targeted delivery applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbubble ultrasound contrast agent (UCA).